drugset
drugset / Trial / NCT06372210

A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion

NCT06372210 ↗

Completed 54 enrolled Otsuka Pharmaceutical Development & Commercialization, Inc.
NaSingle-groupOpen-labelOther

Summary

The primary purpose of the study is to evaluate the positive detection accuracy (PDA) and detection latency measures of the D-Tect patch.

Timeline

Start
2023-06-26
Primary completion
2023-07-19
Completion
2023-07-19

Drugs

EvaluationDrugModalityDoseRoute
Background Aripiprazole Other / unclassified — Oral

Indications

bipolar I disorder major depressive disorder schizophrenia